org placeholder image

Manoj Amaraneni

Head of Regulatory Affairs at Galt Pharmaceuticals

  • LinkedIn

Email Email: m****@galtrx.com

phone noPhone Number: (***)-***-****

• Strongly reliable and focused Regulatory Affairs Specialist with great depth and breadth of experience in bio-pharmaceutical review and evaluation. • Hands on experience in preparing d...

Read More

map
GALT PHARMACEUTICALS

GALT PHARMACEUTICALS

  • description Description
    A unique Pharmaceutical Company, Galt has found a better way to enhance the quality of life of patients with products that meet unmet clinical needs, while creating life-changing opportunitie...

    Read More

  • Employees count Employees 11-50
  • Revenue Revenue 10 Million to 25 Million
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Galt Pharmaceuticals Org Chart and Mapping

Employees

Frequently Asked Questions Regarding Manoj Amaraneni

Answer: Manoj Amaraneni works for Galt Pharmaceuticals as Head of Regulatory Affairs

Answer: Manoj Amaraneni’s role in Galt Pharmaceuticals is Head of Regulatory Affairs

Answer: Manoj Amaraneni's email address is m***@gmail.com

Answer: Manoj Amaraneni's business email address is m****@galtrx.com

Answer: Manoj Amaraneni’s direct phone number is (***)-***-****

Answer: Manoj Amaraneni works in the industry of: Pharmaceuticals

Answer: Manoj Amaraneni is the current Head of Regulatory Affairs at Galt Pharmaceuticals.... Read More

Answer: Manoj Amaraneni works Galt Pharmaceuticals located at 3350 Riverwood Pkwy, Atlanta, Georgia, 30339, United States

Answer: Galt Pharmaceuticals's Head of Regulatory Affairs is Manoj Amaraneni

Answer: Manoj Amaraneni contact details:

  • Phone number  :  (***)-***-****
  • Email  :  m****@galtrx.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access